Aprea Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
APRE
CUSIP
03836J201
Type
Equity
Class
COM NEW
Num filings
24
Total reported value, excl. options
$3.07 M
Manager Report Date Value ($000) Shares Option Type